Prostate Cancer Tumor Stroma: Responsibility in Tumor Biology, Diagnosis and Treatment

被引：8
作者：
Gonzalez, Luis O. [1 ]
Eiro, Noemi [2 ]
Fraile, Maria [2 ]
Beridze, Nana [2 ]
Escaf, Andres R. [2 ]
Escaf, Safwan [3 ]
Fernandez-Gomez, Jesus M. [3 ]
Vizoso, Francisco J. [2 ,4 ]
机构：
[1] Fdn Hosp Jove, Dept Anat Pathol, Avda Eduardo Castro 161, Gijon 33920, Spain
[2] Fdn Hosp Jove, Res Unit, Avda Eduardo Castro 161, Gijon 33920, Spain
[3] Univ Oviedo, Hosp Univ Cent Asturias, Dept Urol, Avda Roma S-N, Oviedo 33011, Spain
[4] Fdn Hosp Jove, Dept Surg, Avda Eduardo Castro 161, Gijon 33920, Spain
来源：
CANCERS | 2022年 / 14卷 / 18期
关键词：
cancer-associated fibroblasts; mesenchymal stromal cells; tumor microenvironment; extracellular vesicles; exosomes; biochemical recurrence in prostate cancer; MESENCHYMAL STEM-CELLS; ANDROGEN DEPRIVATION THERAPY; BREAST-CANCER; EXTRACELLULAR-MATRIX; REACTIVE STROMA; GENE-EXPRESSION; PHASE-II; MICROENVIRONMENTAL REGULATION; CLINICAL-SIGNIFICANCE; MYOEPITHELIAL CELLS;
D O I：
10.3390/cancers14184412
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prostate cancer (PCa) is a common cancer among males globally, and its occurrence is growing worldwide. Clinical decisions about the combination of therapies are becoming highly relevant. However, this is a heterogeneous disease, ranging widely in prognosis. Therefore, new approaches are needed based on tumor biology, from which further prognostic assessments can be established and complementary strategies can be identified. The knowledge of both the morphological structure and functional biology of the PCa stroma compartment can provide new diagnostic, prognostic or therapeutic possibilities. In the present review, we analyzed the aspects related to the tumor stromal component (both acellular and cellular) in PCa, their influence on tumor behavior and the therapeutic response and their consideration as a new therapeutic target.
引用
收藏
页数：25
相关论文
共 258 条
  • [1] Neoplastic Reprogramming of Patient-Derived Adipose Stem Cells by Prostate Cancer Cell-Associated Exosomes
    Abd Elmageed, Zakaria Y.
    Yang, Yijun
    Thomas, Raju
    Ranjan, Manish
    Mondal, Debasis
    Moroz, Krzysztof
    Fang, Zhide
    Rezk, Bashir M.
    Moparty, Krishnarao
    Sikka, Suresh C.
    Sartor, Oliver
    Abdel-Mageed, Asim B.
    [J]. STEM CELLS, 2014, 32 (04) : 983 - 997
  • [2] Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake
    Abels, Erik R.
    Breakefield, Xandra O.
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2016, 36 (03) : 301 - 312
  • [3] Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
    Abida, Wassim
    Cheng, Michael L.
    Armenia, Joshua
    Middha, Sumit
    Autio, Karen A.
    Vargas, Hebert Alberto
    Rathkopf, Dana
    Morris, Michael J.
    Danila, Daniel C.
    Slovin, Susan F.
    Carbone, Emily
    Barnett, Ethan S.
    Hullings, Melanie
    Hechtman, Jaclyn F.
    Zehir, Ahmet
    Shia, Jinru
    Jonsson, Philip
    Stadler, Zsofia K.
    Srinivasan, Preethi
    Laudone, Vincent P.
    Reuter, Victor
    Wolchok, Jedd D.
    Socci, Nicholas D.
    Taylor, Barry S.
    Berger, Michael F.
    Kantoff, Philip W.
    Sawyers, Charles L.
    Schultz, Nikolaus
    Solit, David B.
    Gopalan, Anuradha
    Scher, Howard I.
    [J]. JAMA ONCOLOGY, 2019, 5 (04) : 471 - 478
  • [4] Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma
    Adler, HL
    McCurdy, MA
    Kattan, MW
    Timme, TL
    Scardino, PT
    Thompson, TC
    [J]. JOURNAL OF UROLOGY, 1999, 161 (01) : 182 - 187
  • [5] Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1
    Al Shareef, Zainab
    Kardooni, Hoda
    Murillo-Garzon, Virginia
    Domenici, Giacomo
    Stylianakis, Emmanouil
    Steel, Jennifer H.
    Rabano, Miriam
    Gorrono-Etxebarria, Irantzu
    Zabalza, Ignacio
    Vivanco, Maria dM
    Waxman, Jonathan
    Kypta, Robert M.
    [J]. ONCOGENE, 2018, 37 (39) : 5305 - 5324
  • [6] Alas S, 2001, CLIN CANCER RES, V7, P709
  • [7] High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
    Alexe, Gabricla
    Dalgin, Gul S.
    Scanfeld, Daniel
    Tamayo, Pablo
    Mesirov, Jill P.
    DeLisi, Charles
    Harris, Lyndsay
    Barnard, Nicola
    Martel, Maritza
    Levine, Arnold J.
    Ganesan, Shridar
    Bhanot, Gyan
    [J]. CANCER RESEARCH, 2007, 67 (22) : 10669 - 10676
  • [8] Bone Marrow-Derived Mesenchymal Stromal Cells Harness Purinergenic Signaling to Tolerize Human Th1 Cells In Vivo
    Amarnath, Shoba
    Foley, Jason E.
    Farthing, Don E.
    Gress, Ronald E.
    Laurence, Arian
    Eckhaus, Michael A.
    Metais, Jean-Yves
    Rose, Jeremy J.
    Hakim, Frances T.
    Felizardo, Tania C.
    Cheng, Austin V.
    Robey, Pamela G.
    Stroncek, David E.
    Sabatino, Marianna
    Battiwalla, Minoo
    Ito, Sawa
    Fowler, Daniel H.
    Barrett, Austin J.
    [J]. STEM CELLS, 2015, 33 (04) : 1200 - 1212
  • [9] On the origin of cancer-associated fibroblasts
    Anderberg, Charlotte
    Pietras, Kristian
    [J]. CELL CYCLE, 2009, 8 (10) : 1461 - 1462
  • [10] Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
    Antonarakis, Emmanuel S.
    Kibel, Adam S.
    Yu, Evan Y.
    Karsh, Lawrence I.
    Elfiky, Aymen
    Shore, Neal D.
    Vogelzang, Nicholas J.
    Corman, John M.
    Millard, Frederick E.
    Maher, Johnathan C.
    Chang, Nancy N.
    DeVries, Todd
    Sheikh, Nadeem A.
    Drake, Charles G.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2451 - 2459
12345678910